The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...
announced the publication of new data in the journal BJUI Compass that demonstrate the clinical validation of OncoAssure Prostate, a novel biopsy test that provides improved estimation of a ...
In a new study, researchers at the University ... the team modified the urine collection approach so that the MPS2 test could detect markers for prostate cancer, without requiring a prior rectal ...
Opens in a new tab or window Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer ...